ACADIA Pharmaceuticals's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
ACADIA Pharmaceuticals (NASDAQ:ACAD) is set to release its latest quarterly earnings report on August 2, 2023. Analysts estimate an earnings per share (EPS) of $-0.12. The company's past performance shows a pattern of share price changes following earnings reports. ACADIA's shares were trading at $29.24 as of July 31, with a 92.43% increase over the last 52-week period.
August 04, 2023 | 10:08 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
ACADIA Pharmaceuticals is expected to report an EPS of $-0.12 in its upcoming earnings. The company's stock price has historically been affected by its earnings reports. The stock is up 92.43% over the last 52 weeks.
ACADIA Pharmaceuticals' upcoming earnings report is expected to have a significant impact on its stock price, as has been the case in the past. However, it's uncertain whether the impact will be positive or negative, as it depends on whether the company meets, exceeds, or falls short of the estimated EPS. The stock's strong performance over the past year indicates investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100